Biomarker ID | 1882 |
PMID | 30623593 |
Year | 2018 |
Biomarker | Keratin, type II cytoskeletal 2 epidermal; Serum amyloid Pâ€component;Keratin, type II cytoskeletal 1; Keratin, type I cytoskeletal 9; Isoform 2 of Filamin A; Isoform 3 of Vitamin Dâ€binding protein; Ig kappa chain Vâ€II region Cum; soform 2 of Eukaryotic translation initiation 1.8 factor 2â€alpha kinase 4; Ig alphaâ€1 chain C region; Afamin; |
Biomarker Basis | Concentration Based |
Biomolecule | Protein |
Source | Serum |
Subjects | Humans |
Regulation | Increased in Progression Free survival |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | NA |
Experiment | Prostate Cancer in African American Men Vs Normal African American Men |
Type of Biomarker | Diagnostic |
Cohort | Serum samples from African American and Caucasian PCa patients and matched healthy donors were collected after patients’ consents |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p<0.05 |
Method Used | mass spectrometry |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |